Vincerx Pharma, Inc.

NasdaqCM:VINC Stock Report

Market Cap: US$22.2m

Vincerx Pharma Management

Management criteria checks 4/4

Vincerx Pharma's CEO is Ahmed Hamdy, appointed in Dec 2020, has a tenure of 3.58 years. total yearly compensation is $734.95K, comprised of 65.2% salary and 34.8% bonuses, including company stock and options. directly owns 5.8% of the company’s shares, worth $1.29M. The average tenure of the management team and the board of directors is 3.2 years and 3.4 years respectively.

Key information

Ahmed Hamdy

Chief executive officer

US$735.0k

Total compensation

CEO salary percentage65.2%
CEO tenure3.6yrs
CEO ownership5.8%
Management average tenure3.2yrs
Board average tenure3.4yrs

Recent management updates

Recent updates

Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?

Jul 18
Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?

Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?

Mar 30
Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?

Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?

Sep 22
Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?

Is Vincerx Pharma (NASDAQ:VINC) In A Good Position To Invest In Growth?

Jun 24
Is Vincerx Pharma (NASDAQ:VINC) In A Good Position To Invest In Growth?

Vincerx Pharma doses first patient in early-stage VIP152 cancer study

Jun 03

CEO Compensation Analysis

How has Ahmed Hamdy's remuneration changed compared to Vincerx Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-US$38m

Dec 31 2023US$735kUS$479k

-US$40m

Sep 30 2023n/an/a

-US$47m

Jun 30 2023n/an/a

-US$54m

Mar 31 2023n/an/a

-US$61m

Dec 31 2022US$1mUS$460k

-US$63m

Sep 30 2022n/an/a

-US$58m

Jun 30 2022n/an/a

-US$66m

Mar 31 2022n/an/a

-US$49m

Dec 31 2021US$615kUS$460k

-US$39m

Sep 30 2021n/an/a

-US$49m

Jun 30 2021n/an/a

-US$25m

Mar 31 2021n/an/a

-US$23m

Dec 31 2020US$622kUS$15k

-US$17m

Compensation vs Market: Ahmed's total compensation ($USD734.95K) is about average for companies of similar size in the US market ($USD702.33K).

Compensation vs Earnings: Ahmed's compensation has been consistent with company performance over the past year.

CEO

Ahmed Hamdy (59 yo)

3.6yrs

Tenure

US$734,953

Compensation

Dr. Ahmed M. Hamdy, M.D., is Co-Founder of Vincerx Pharma, Inc. (formerly known as Vincera Pharma, Inc.) and has been its Chief Executive Officer and Chairman of the Board since December 2020. He served as...

Leadership Team

NamePositionTenureCompensationOwnership
Ahmed Hamdy
Co-Founder3.6yrsUS$734.95k5.8%
$ 1.3m
Raquel Izumi
Co-Founder3.6yrsUS$668.96k0.29%
$ 64.7k
Alexander Seelenberger
Chief Financial Officer3.6yrsUS$565.67k0.11%
$ 24.9k
Tom Thomas
Founder3.3yrsUS$3.16mno data
John Byrd
Founder & Chairman of Scientific Advisory Boardno datano data5.48%
$ 1.2m
Hans-Georg Lerchen
Chief Scientific Officer3.3yrsno datano data
Gabriela Jairala
Sr Executive Director of Investor Relations & Corporate Communicationsless than a yearno datano data
Karen Quarford
Vice President of Quality Operations & Compliance1.5yrsno datano data
Melissa Merrick
Senior Director of People & Culture and Head of Human Resource2.9yrsno datano data
Beatrix Stelte-Ludwig
Executive Chief Development Officer3.2yrsno datano data
Steven Bloom
Chief Business Officer1.1yrsno datano data
Raj Dua
VP of Biologics Development and Manufacturing and Sr. VP of Chemistry & Manufacturing1.1yrsno datano data

3.2yrs

Average Tenure

59yo

Average Age

Experienced Management: VINC's management team is considered experienced (3.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Ahmed Hamdy
Co-Founder3.6yrsUS$734.95k5.8%
$ 1.3m
Raquel Izumi
Co-Founder3.6yrsUS$668.96k0.29%
$ 64.7k
John Byrd
Founder & Chairman of Scientific Advisory Board3.3yrsno data5.48%
$ 1.2m
Francisco Salva
Independent Director3.6yrsUS$69.14k0%
$ 0
Brian Druker
Independent Director3.6yrsUS$47.89k0.19%
$ 41.1k
Anthony Tolcher
Member of Scientific Advisory Board3.3yrsno datano data
Laura Bushnell
Independent Director3.6yrsUS$52.89k0.065%
$ 14.4k
Ruth Stevens
Independent Director3.2yrsUS$47.89k0%
$ 0
Howard Burris
Member of Scientific Advisory Board3.3yrsno datano data
Ian Flinn
Member of Scientific Advisory Board3.3yrsno datano data
Andre Goy
Member of Scientific Advisory Board3.3yrsno datano data
John Lee
Independent Director3.6yrsUS$47.89k0.0027%
$ 600.3

3.4yrs

Average Tenure

56yo

Average Age

Experienced Board: VINC's board of directors are considered experienced (3.4 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.